Malar J

Human movement data for malaria control and elimination strategic planning.Pindolia DK Garcia AJ Wesolowski A Smith DL Buckee CO Noor AM Snow RW Tatem AJ
Malar J, (2012). 11:205

Local perceptions of intermittent screening and treatment for malaria in school children on the south coast of Kenya.Okello G Ndegwa SN Halliday KE Hanson K Brooker SJ Jones C
Malar J, (2012). 11:185

Inaugural meeting of the malaria policy advisory committee to the WHO: conclusions and recommendations.WHOMalaria Policy Advisory Committee Secretariat,
Malar J, (2012). 11:137

The magnitude and trend of artemether-lumefantrine stock-outs at public health facilities in Kenya.Sudoi RK Githinji S Nyandigisi A Muturi A Snow RW Zurovac D
Malar J, (2012). 11:37

Impact of insecticide-treated bed nets on malaria transmission indices on the south coast of Kenya.Mutuku FM King CH Mungai P Mbogo C Mwangangi J Muchiri EM Walker ED Kitron U
Malar J, (2011). 10:356

Monitoring fever treatment behaviour and equitable access to effective medicines in the context of initiatives to improve ACT access: baseline results and implications for programming in six African countries.Littrell M Gatakaa H Evance I Poyer S Njogu J Solomon T Munroe E Chapman S Goodman C Hanson K Zinsou C Akulayi L Raharinjatovo J Arogundade E Buyungo P Mpasela F Adjibabi CB Agbango JA Ramarosandratana BF Coker B Rubahika D Hamainza B Shewchuk T Chavasse D O'Connell KA
Malar J, (2011). 10:327

Got ACTs? Availability, price, market share and provider knowledge of anti-malarial medicines in public and private sector outlets in six malaria-endemic countries.O'Connell KA Gatakaa H Poyer S Njogu J Evance I Munroe E Solomon T Goodman C Hanson K Zinsou C Akulayi L Raharinjatovo J Arogundade E Buyungo P Mpasela F Adjibabi CB Agbango JA Ramarosandratana BF Coker B Rubahika D Hamainza B Chapman S Shewchuk T Chavasse D
Malar J, (2011). 10:326

The ACTwatch project: methods to describe anti-malarial markets in seven countries.Shewchuk T O'Connell KA Goodman C Hanson K Chapman S Chavasse D
Malar J, (2011). 10:325

Adherence to prescribed artemisinin-based combination therapy in Garissa and Bunyala districts, Kenya.Lawford H Zurovac D O'Reilly L Hoibak S Cowley A Munga S Vulule J Juma E Snow RW Allan R
Malar J, (2011). 10:281

Cost analysis of school-based intermittent screening and treatment of malaria in Kenya.Drake TL Okello G Njagi K Halliday KE Jukes MCh Mangham L Brooker S
Malar J, (2011). 10:273

Development of standardized laboratory methods and quality processes for a phase III study of the RTS, S/AS01 candidate malaria vaccine.Swysen C Vekemans J Bruls M Oyakhirome S Drakeley C Kremsner P Greenwood B Ofori-Anyinam O Okech B Villafana T Carter T Savarese B Duse A Reijman A Ingram C Frean J Ogutu B Clinical Trials Partnership Committee
Malar J, (2011). 10:223

Assessment of severe malaria in a multicenter, phase III, RTS, S/AS01 malaria candidate vaccine trial: case definition, standardization of data collection and patient care.Vekemans J Marsh K Greenwood B Leach A Kabore W Soulanoudjingar S Asante KP Ansong D Evans J Sacarlal J Bejon P Kamthunzi P Salim N Njuguna P Hamel MJ Otieno W Gesase S Schellenberg D Clinical Trials Partnership Committee
Malar J, (2011). 10:221

Statistical methodology for the evaluation of vaccine efficacy in a phase III multi-centre trial of the RTS, S/AS01 malaria vaccine in African children.Lievens M Aponte JJ Williamson J Mmbando B Mohamed A Bejon P Leach A
Malar J, (2011). 10:222

Design of a phase III multicenter trial to evaluate the efficacy of the RTS,S/AS01 malaria vaccine in children across diverse transmission settings in Africa.Leach A Vekemans J Lievens M Ofori-Anyinam O Cahill C Owusu-Agyei S Abdulla S Macete E Njuguna P Savarese B Loucq C Ballou WR Clinical Trials Partnership Committee
Malar J, (2011). 10:224

Global proteomic analysis of plasma from mice infected with Plasmodium berghei ANKA using two dimensional gel electrophoresis and matrix assisted laser desorption ionization-time of flight mass spectrometry.Gitau EN Kokwaro GO Newton CR Ward SA
Malar J, (2011). 10:205

Treatment of African children with severe malaria - towards evidence-informed clinical practice using GRADE.Musila N Opiyo N English M
Malar J, (2011). 10:201

The clinical burden of malaria in Nairobi: a historical review and contemporary audit.Mudhune SA Okiro EA Noor AM Zurovac D Juma E Ochola SA Snow RW
Malar J, (2011). 10:138

Self-reported fever, treatment actions and malaria infection prevalence in the northern states of Sudan.Elmardi KA Noor AM Githinji S Abdelgadir TM Malik EM Snow RW
Malar J, (2011). 10:128

A phase I trial to evaluate the safety and pharmacokinetics of low-dose methotrexate as an anti-malarial drug in Kenyan adult healthy volunteers.Chilengi R Juma R Abdallah AM Bashraheil M Lodenyo H Nyakundi P Anabwani E Salim A Mwambingu G Wenwa E Jemutai J Kipkeu C Oyoo GO Muchohi SN Kokwaro G Niehues T Lang T Nzila A
Malar J, (2011). 10:63

Effect of HIV infection on the acute antibody response to malaria antigens in children: an observational study.Muema DK Ndungu FM Kinyanjui SM Berkley JA
Malar J, (2011). 10:55